A PHASE II STUDY OF SORAFENIB AND METFORMIN IN PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER (NSCLC) WITH A KRAS MUTATION

  • Wouter W. Mellema
  • , Sjaak Burgers
  • , Harry J. M. Groen
  • , Anne-Marie Dingemans
  • , Erik Thunnissen
  • , Danielle A. M. Heideman
  • , Jeroen De Jong
  • , Wim Timens
  • , Ernst-Jan M. Speel
  • , Egbert F. Smit

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)S1205-S1205
Number of pages1
JournalJournal of Thoracic Oncology
Volume8
Publication statusPublished - Nov-2013

Keywords

  • non-small cell lung cancer
  • KRAS
  • Sorafenib and metformin
  • Phase II study

Cite this